Search Results 201-210 of 15230 for TNF

1. A Study of the Use of a New Drug in People with Non-Alcoholic Steatohepatitis (NASH) or Non-Alcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

   Additionally, if subjects are taking drugs such Vit E, Ursodeoxycholic acid, Gemfibrozil, anti TNF therapies and probiotics will be allowed if on stable ...

2. Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM - Mayo Clinic

   Receiving TNF pathway inhibitors, PI3 kinase inhibitors, systemic steroid therapy or any other form of immunosuppressive therapy within 7 days prior to the ...

3. CAST-AI: Cystectomy after systemic therapy with ADC and Immunotherapy - Mayo Clinic

   ... tumor necrosis factor (TNF) or anti-interleukin (IL)-6 agents are excluded * Participants still recovering from toxicity of prior anticancer therapy which ...

4. A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

   Contraindications to the use of golimumab or infliximab or anti-tumor necrosis factor (TNF-alpha) therapy per local prescribing information. Participating ...

5. Publications - Michael M. Pham, M.D. - Mayo Clinic

   Intra-articular therapy with methotrexate or tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic review. BMC Musculoskelet Disord. 2021 ...

6. Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer - Mayo Clinic

   ... tumor necrosis factor [anti-TNF] agents) within 6 weeks prior to cycle 1 day 1: Patients who have received acute, low dose, systemic immunosuppressant ...

7. Induction Therapy With RO7790121 in Patients With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

   RO7790121 is a fully human immunoglobulin G1 monoclonal antibody (mAb) against tumor necrosis factor-like ligand 1A (TL1A). TL1A plays a central role in the ...

8. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

9. A Study to Evaluate CC-98633 to Treat Subjects with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

   ... TNF, anti-IL6, or anti-IL6R) or in need of such therapies;; Donor lymphocyte infusions within 6 weeks before leukapheresis;; Radiation to a single lesion or a ...

10. Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis - Mayo Clinic

    TNF-alpha inhibitors including but not limited to infliximab (Remicade) or ... Recently, antibodies against the proinflammatory cytokine tumor necrosis factor ...